Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 540

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 540
---
 summary of the status of the Company’s nonvested warrants as of December 31, 2024, and changes during the year ended December 31, 2024, is presented below:

| Non-vested Warrants             
 Non-vested at December 31, 2023 |     | Warrants 
        — |     | Weighted- 
   Average 
  Exercise 
     Price 
        $— |
|:--------------------------------|:----|---------:|:----|----------:|
| Granted                         |     |   55,000 |     |     $7.50 |
| Vested                          |     |  -55,000 |     |     $7.50 |
| Forfeited                       |     |        — |     |        $— |
| Non-vested at December 31, 2024 |     |        — |     |        $— |

The total number of warrants granted during the years ended December 31, 2024 and 2023 was 55,000 and 0, respectively. The exercise price for these warrants was $7.50 per share and there was an intrinsic value of $0. The Company recognized stock-based compensation expense related to warrant vesting amortization of $0 and $0 for the years ended December 31, 2024 and 2023, respectively. On February 21, 2024, the Company issued warrants to purchase up to 55,000 shares of Common Stock to the representative of the underwriters of the IPO (the “Representative”). These warrants have an exercise price of $7.50, have a cashless exercise provision, are exercisable 180 days following the commencement of sales of the shares of Common Stock of the IPO and have an expiration date of February 21, 2029. No expense was recognized to the warrants issued to such warrants from the IPO as these warrants constituted offering costs of the IPO.

F-45

TABLE OF CONTENTS

RSUs A summary of the status of the Company’s nonvested RSUs as of December 31, 2024, and changes during the year ended December 31, 2024, is presented below:

| Non-vested RSUs                 
 Non-vested at December 31, 2023 |     |    RSUs 
       — |     | Weighted- 
   Average 
  Exercise 
     Price 
        $— |
|:--------------------------------|:----|--------:|:----